Tumor Necrosis Factor Induces Lipopolysaccharide Tolerance in a Human Adenocarcinoma Cell Line Mainly through the TNF p55 Receptor
Open Access
- 1 October 1995
- journal article
- Published by Elsevier
- Vol. 270 (43) , 25418-25425
- https://doi.org/10.1074/jbc.270.43.25418
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptorCell, 1994
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced “Acidic” sphingomyelin breakdownCell, 1992
- Anti-tumor necrosis factor receptor and tumor necrosis factor agonist activity by an anti-idiotypic antibodyEuropean Journal of Immunology, 1992
- Membrane molecules which trigger the production of interleukin‐1 and tumor necrosis factor‐α by lipopolysaccharide‐stimulated human monocytesEuropean Journal of Immunology, 1992
- Lipopolysaccharide antagonistsImmunology Today, 1992
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990
- Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor.The Journal of Experimental Medicine, 1990
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985